The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

Simplicity is hard. For all the breezy and cavalier rhetoric that pushy investors, bankers and CEOs use to tout the benefits ...

Adjusting asset-class exposure based on changing market conditions sounds good in theory but usually doesn’t work.